Clinical Trials Browser

OTHER × Recurrence × tipifarnib × Clear all

NCT00847223 2018-08-23

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Phase 2 Terminated

Lymphoma, Recurrence, Lymphoma, Mantle-Cell